v3.25.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
AOCI Attributable to Parent [Member]
Balance at beginning of period at Dec. 31, 2023 $ 429,405 $ 23,373 $ 136,866 $ 357,260 $ 69 $ (88,163)
Cash dividends declared (8,775)     (8,775)    
Issuance of shares of common stock pursuant to dividend reinvestment plan 6,405 179 6,226      
Issuance of shares of common stock pursuant to exercise of stock options 109 6 103      
Vesting of performance stock units   1 (1)      
Vesting of restricted stock units   5 (5)      
Repurchase of common shares (2,181) (60) (2,121)      
Share based compensation expense 589   589      
Net change in fair value of available-for-sale securities during the period, net of taxes (5,467)         (5,467)
Net earnings for the quarter 28,972     28,905 67  
Balance at end of period at Jun. 30, 2024 449,057 23,504 141,657 377,390 136 (93,630)
Balance at beginning of period at Mar. 31, 2024 435,519 23,557 143,460 361,253 80 (92,831)
Issuance of shares of common stock pursuant to exercise of stock options 15 2 13      
Vesting of restricted stock units   5 (5)      
Repurchase of common shares (2,181) (60) (2,121)      
Share based compensation expense 310   310      
Net change in fair value of available-for-sale securities during the period, net of taxes (799)         (799)
Net earnings for the quarter 16,193     16,137 56  
Balance at end of period at Jun. 30, 2024 449,057 23,504 141,657 377,390 136 (93,630)
Balance at beginning of period at Dec. 31, 2024 479,703 23,754 150,739 393,238 203 (88,231)
Cash dividends declared (11,902)     (11,902)    
Issuance of shares of common stock pursuant to dividend reinvestment plan 8,466 225 8,241      
Issuance of shares of common stock pursuant to exercise of stock options 82 10 72      
Vesting of performance stock units   1 (1)      
Vesting of restricted stock units   11 (11)      
Share based compensation expense 566   566      
Net change in fair value of available-for-sale securities during the period, net of taxes 18,737         18,737
Net earnings for the quarter 35,532     35,507 25  
Sale of subsidiary interest (228)       (228)  
Balance at end of period at Jun. 30, 2025 530,956 24,001 159,606 416,843   (69,494)
Balance at beginning of period at Mar. 31, 2025 506,355 23,988 159,302 397,728 208 (74,871)
Issuance of shares of common stock pursuant to exercise of stock options 29 7 22      
Vesting of restricted stock units   6 (6)      
Share based compensation expense 288   288      
Net change in fair value of available-for-sale securities during the period, net of taxes 5,377         5,377
Net earnings for the quarter 19,135     19,115 20  
Sale of subsidiary interest (228)       $ (228)  
Balance at end of period at Jun. 30, 2025 $ 530,956 $ 24,001 $ 159,606 $ 416,843   $ (69,494)